前往寄宿学校:探索医生在瘤委员会中的学习方式
1Division of Pediatric Hematology/Oncology/BMT, The Ohio State University College of Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
Pediatric blood & cancer
|August 23, 2023
概括
医生在多学科瘤委员会 (TB) 中通过合作和相互教学来学习. 优化这些互动可以提高结核病对所有参与者的教育价值.
科学领域:
- 在瘤学瘤学.
- 医学教育 医学教育
- 定性研究是指质量研究.
背景情况:
- 瘤委员会 (TB) 需要在瘤学领域举办多学科会议.
- 证据支持结核病在临床决策和感知学习价值中的作用.
- 关于医生在结核病环境中如何学习的数据有限.
研究的目的:
- 探索瘤委员会参与医生的学习经验.
- 在多学科癌症病例会议期间确定影响医生学习的因素.
主要方法:
- 一个探索性的,使用自然主义调查的定性研究.
- 半结构面试对15名有意抽样的医生参与者进行了半结构面试.
- 采访数据被转录和分析以确定新出现的主题.
主要成果:
- 利益相关者之间共同的教育目标增强了学习.
- 展示案例对于实习生学习至关重要.
- 在演讲期间的讨论和协作促进了与会者的学习.
- 参与者积极培养一个共享的学习环境.
- 虚拟结核病格式可以影响参与者的参与和学习.
结论:
- 在TB中学习与认知学徒模式保持一致.
- 识别学习促进者和抑制者可以优化教育过程.
- 结核病在实践社区中体现了学习的社会性质.
相关概念视频
Tumor Immunotherapy
556
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Cancer Survival Analysis
383
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
383
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


